论文部分内容阅读
目的探讨胺碘酮治疗急性心肌梗死后室性心律失常的临床疗效。方法选取2012年6月—2014年7月天津医科大学总医院收治的急性心肌梗死后室性心律失常患者104例,采用随机数字表法分为对照组与观察组,各52例。对照组患者予以利多卡因治疗,观察组患者予以胺碘酮治疗。观察两组患者心脏不良事件、不良反应发生情况、平均复律时间及临床疗效。结果观察组患者心脏不良事件、不良反应发生率低于对照组,平均复律时间短于对照组,差异有统计学意义(P<0.05);观察组患者总有效率高于对照组,差异有统计学意义(P<0.05)。结论胺碘酮治疗急性心肌梗死后室性心律失常的临床疗效显著,且不良反应少。
Objective To investigate the clinical efficacy of amiodarone in the treatment of ventricular arrhythmias after acute myocardial infarction. Methods A total of 104 patients with ventricular arrhythmia after acute myocardial infarction admitted to Tianjin Medical University General Hospital from June 2012 to July 2014 were randomly divided into control group and observation group with 52 cases in each group. Patients in the control group were treated with lidocaine, and patients in the observation group were treated with amiodarone. Adverse events, adverse reactions, mean duration of cardioversion and clinical effects were observed in two groups. Results The incidence of adverse cardiac events and adverse reactions in observation group were lower than those in control group, and the average duration of cardioversion was shorter than that in control group (P <0.05). The total effective rate in observation group was higher than that in control group Statistical significance (P <0.05). Conclusion The clinical efficacy of amiodarone in the treatment of ventricular arrhythmia after acute myocardial infarction is remarkable with less adverse reactions.